Approval · Notice of Compliance 1259 · 2000
EMLA: Notice of Compliance 1259
Issued May 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1259
- Date
- May 9, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Topical anesthetic
Products in this notice
Medicinal ingredients
- LIDOCAINE 25 MG per G
- PRILOCAINE 25 MG per G
- LIDOCAINE 2.5 PER
- PRILOCAINE 2.5 PER